Intrinsiqq
Grace Therapeutics Inc. logo

Grace Therapeutics Inc. Insider Trading

GRCE

Compare
Last 12 months

Insiders bought 214K on the open market and sold nothing.

Net open-market
+214K
1 buy · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
1 / 0
executives and directors
Last open-market buy
Sep 2026
Sep 9, 2026

Get an email when GRCE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 16 – 18
    Opaleye Management Inc.
    Large holder · bought 48,060 at avg $1.74
    83K
    1.6% of stake
  • Nov 3 – 5
    Opaleye Management Inc.
    Large holder · bought 18,442 at avg $1.79
    33K
    0.6% of stake
  • Oct 22 – 26
    Opaleye Management Inc.
    Large holder · bought 87,801 at avg $1.81
    159K
    3.0% of stake
  • Oct 19
    Opaleye Management Inc.
    Large holder · bought 4,256 at $1.88
    8K
    0.1% of stake
  • Oct 14 – 16
    Opaleye Management Inc.
    Large holder · bought 71,065 at avg $1.92
    136K
    2.5% of stake
  • Oct 8 – 12
    Opaleye Management Inc.
    Large holder · bought 14,632 at avg $2.03
    30K
    0.5% of stake
  • Oct 1 – 5
    Opaleye Management Inc.
    Large holder · bought 60,490 at avg $2.05
    124K
    2.2% of stake
  • Sep 29
    Opaleye Management Inc.
    Large holder · bought 7,849 at $2.09
    16K
    0.3% of stake
  • Sep 21 – 23
    Opaleye Management Inc.
    Large holder · bought 15,089 at avg $2.10
    32K
    0.5% of stake
  • Sep 8 – 9
    Opaleye Management Inc.
    Large holder · bought 15,229 at avg $2.10
    32K
    0.6% of stake
  • Sep 9
    Prashant Kohli
    Chief Executive Officer · bought 100,000 at $2.14
    214K
    468% of stake
  • Aug 14
    Opaleye Management Inc.
    Large holder · bought 11,608 at $2.09
    24K
    0.4% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch GRCE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with GRCE

CompareIntrinsic value
RCUSArcus Biosciences Inc.
$15.62-1.01%10
ASRTAssertio Holdings Inc.
$9.06+0.28%10
SEPNSepterna, Inc.
$38.61-1.51%25
TBPHTheravance Biopharma Inc.
No recent price82
FHTXFoghorn Therapeutics Inc.
$1.72-3.37%46
AMLXAmylyx Pharmaceuticals, Inc.
$26.02-0.69%10
CYTKCytokinetics, Incorporated
$50.78-1.32%18
LFCRLifecore Biomedical, Inc.
$6.39+0.31%21

Spot a number that looks wrong? Check it in GRCE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing GRCE

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.